1-deoxynojirimycin has been researched along with Cognitive Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calì, F; Costanzo, MC; Fiumara, A; Musumeci, SA; Nicotera, AG; Vinci, M; Vitello, A | 1 |
| De Rosa, A; Dubbioso, R; Esposito, M; Iodice, R; Manganelli, F; Ruggiero, L; Saccà, F; Santoro, L; Spina, E; Topa, A; Tozza, S | 1 |
| Chen, W; Li, C; Liang, T; Peng, G; Shen, Z; Wang, F; Wu, X; Zheng, Y; Zuo, W | 1 |
| Eratne, D; Farrand, S; Goh, AMY; Kelso, W; Mangelsdorf, S; Rego, T; Velakoulis, D; Walterfang, M | 1 |
1 review(s) available for 1-deoxynojirimycin and Cognitive Dysfunction
| Article | Year |
|---|---|
Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management.
Topics: 1-Deoxynojirimycin; 2-Hydroxypropyl-beta-cyclodextrin; Animals; Brain; Cognitive Dysfunction; Diagnosis, Differential; GABAergic Neurons; Humans; Models, Neurological; Neuronal Plasticity; Niemann-Pick Disease, Type C; Psychotic Disorders | 2019 |
3 other study(ies) available for 1-deoxynojirimycin and Cognitive Dysfunction
| Article | Year |
|---|---|
Novel compound heterozygous mutation in
Topics: 1-Deoxynojirimycin; Adult; Apathy; Brain; Cognitive Dysfunction; Corpus Callosum; Deglutition Disorders; Female; High-Throughput Nucleotide Sequencing; Humans; Intracellular Signaling Peptides and Proteins; Language Disorders; Magnetic Resonance Imaging; Mutation, Missense; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Vesicular Transport Proteins | 2020 |
Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.
Topics: 1-Deoxynojirimycin; Adult; Cognitive Dysfunction; Enzyme Inhibitors; Female; Humans; Niemann-Pick Disease, Type C; Siblings; Treatment Failure | 2018 |
Neuroprotective effect of 1-Deoxynojirimycin on cognitive impairment, β-amyloid deposition, and neuroinflammation in the SAMP8 mice.
Topics: 1-Deoxynojirimycin; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Cognitive Dysfunction; Disease Models, Animal; Encephalitis; Hippocampus; Inflammation Mediators; Male; Membrane Glycoproteins; Memory; Mice, Inbred Strains; Microglia; Neuroprotective Agents; Protein-Tyrosine Kinases; Signal Transduction; Time Factors | 2018 |